Trial Profile
A Prospective Observational Study of the Efficacy and Safety of CPT-11 Plus Platinum Analogues Regimens for UGT1A1 Genotype Guided Patients With Several Solid Tumors.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Carboplatin; Cisplatin; Nedaplatin
- Indications Cervical cancer; Gastric cancer; Non-small cell lung cancer; Ovarian cancer; Small cell lung cancer
- Focus Adverse reactions; Pharmacogenomic
- Sponsors Daiichi Sankyo Inc
- 21 May 2019 Status changed from active, no longer recruiting to completed.
- 28 Mar 2013 Planned End Date changed from 1 Mar 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
- 28 Mar 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.